Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.
Pasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F. Pasquer H, et al. Among authors: damy t. Br J Haematol. 2021 May;193(3):674-677. doi: 10.1111/bjh.17380. Epub 2021 Mar 13. Br J Haematol. 2021. PMID: 33713427 No abstract available.
(99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis.
Galat A, Van Der Gucht A, Colombat M, Attias D, Itti E, Meignan M, Lebras F, Molinier-Frenkel V, Benhaiem N, Guellich A, Rosso J, Damy T. Galat A, et al. Among authors: damy t. J Nucl Cardiol. 2015 Aug;22(4):853-7. doi: 10.1007/s12350-015-0176-6. Epub 2015 May 22. J Nucl Cardiol. 2015. PMID: 26002815
Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients.
Nielsen L, Canouï-Poitrine F, Jais JP, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V. Nielsen L, et al. Among authors: damy t. Br J Haematol. 2016 Jul;174(1):148-52. doi: 10.1111/bjh.14040. Epub 2016 Mar 17. Br J Haematol. 2016. PMID: 26992059 Free article.
[Cardiac amyloidosis: How to recognize them and manage them?].
Bodez D, Galat A, Guellich A, Deux JF, Rosso J, Le Bras F, Funalot B, Fanen P, Benhaiem N, Planté-Bordeneuve V, Dubois-Randé JL, Lellouche N, Guendouz S, Molinier-Frenkel V, Mohty D, Damy T. Bodez D, et al. Among authors: damy t. Presse Med. 2016 Oct;45(10):845-855. doi: 10.1016/j.lpm.2016.07.001. Epub 2016 Aug 1. Presse Med. 2016. PMID: 27492996 French.
Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis.
Le Bras F, Molinier-Frenkel V, Guellich A, Dupuis J, Belhadj K, Guendouz S, Ayad K, Colombat M, Benhaiem N, Tissot CM, Hulin A, Jaccard A, Damy T. Le Bras F, et al. Among authors: damy t. Eur J Cancer. 2017 May;76:183-187. doi: 10.1016/j.ejca.2017.02.004. Epub 2017 Mar 20. Eur J Cancer. 2017. PMID: 28334621
Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis.
Dang J, Abulizi M, Moktefi A, El Karoui K, Deux JF, Bodez D, Le Bras F, Belhadj K, Remy P, Issaurat P, Plante-Bordeneuve V, Molinier-Frenkel V, Fanen P, Guendouz S, Kharoubi M, Itti E, Damy T, Audard V. Dang J, et al. Among authors: damy t. Mayo Clin Proc. 2019 Jun;94(6):961-975. doi: 10.1016/j.mayocp.2019.02.012. Epub 2019 May 15. Mayo Clin Proc. 2019. PMID: 31103217
Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value.
Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, Moktefi A, Guendouz S, Molinier-Frenkel V, Fanen P, Funalot B, Lefaucheur JP, Blanc-Durand P, Deux JF, Audard V, Bodez D, Itti E, Damy T. Malka N, et al. Among authors: damy t. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2396-2406. doi: 10.1007/s00259-020-04753-7. Epub 2020 Mar 10. Eur J Nucl Med Mol Imaging. 2020. PMID: 32157431
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment.
Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F. Gounot R, et al. Among authors: damy t. Leuk Lymphoma. 2021 Apr;62(4):979-983. doi: 10.1080/10428194.2020.1850717. Epub 2020 Nov 29. Leuk Lymphoma. 2021. PMID: 33251891 No abstract available.
[Cardiac amyloidosis].
Poullot E, Oghina S, Kalsoum S, Damy T. Poullot E, et al. Among authors: damy t. Ann Pathol. 2021 Feb;41(1):25-37. doi: 10.1016/j.annpat.2020.11.010. Epub 2021 Jan 6. Ann Pathol. 2021. PMID: 33422349 French.
281 results